Meet our team

5AM’s investment professionals possess strong scientific, medical, operational, legal and financial expertise. Our complementary backgrounds provide us with a unique edge to find and shape life science portfolio companies.

Investment Team
  • Kush M. Parmar, MD, PhD
    Managing Partner
  • Andrew J. Schwab
    Managing Partner
  • David Allison, PhD
    Partner
  • Brian Daniels, MD
    Partner
  • Deb Palestrant, PhD
    Partner, Head of 4:59
  • Paul Barsanti, PhD
    Executive-in-Residence
  • Jamil M. Beg
    Principal
  • Galya Blachman, PhD, Esq
    General Counsel
  • Amy Burroughs
    Executive-in-Residence
  • Mira Chaurushiya, PhD
    Principal
  • John D. Diekman, PhD
    FOUNDING PARTNER
  • Elliot Ehrich, MD
    Venture Partner
  • Mason Freeman, MD
    Venture Partner
  • Mark A. Gallop, PhD
    Executive-in-Residence
  • Michelle Ho, PhD
    Analyst
  • Peter S. Kim, PhD
    Venture Partner
  • Rebecca Lucia, CFA
    Chief Financial Officer / Chief Operating Officer
  • Vamsi Mootha, MD
    Venture Partner
  • Scott M. Rocklage, PhD
    FOUNDING PARTNER
  • Jason Ruth, PhD
    Associate
  • Anjanabha Saha, PhD
    Executive-in-Residence
  • Paul A. Stone, JD
    Of Counsel
  • Lou Tartaglia, PhD
    Venture Partner
  • Richard J. Ulevitch, PhD
    Venture Partner
  • Joseph J. Victor
    Venture Partner
  • Jonathan Weissman, PhD
    Venture Partner
  • James W. Young, PhD
    Venture Partner